12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 13 10 2017
accepted: 09 07 2018
pubmed: 18 7 2018
medline: 10 1 2020
entrez: 18 7 2018
Statut: ppublish

Résumé

Major depressive disorder (MDD) and bipolar disorder are associated with certain cardiovascular risk factors (CVRFs), but it is unclear whether they are associated with unfavourable changes of clinically manifest CVRFs over time. We used baseline and 12-year follow-up (n = 1887) data from the German Health Interview and Examination Survey 1998. Multivariable linear regression models assessed associations between lifetime CIDI-diagnosed mood disorders at baseline and continuous risk factor-related outcomes (blood pressure, HbA1c, LDL-C, HDL-C, triglycerides, BMI) at follow-up. We did not find consistent deterioration of CVRFs in persons with compared to persons without MDD. Analyses pointed to severity of mood disorder as an important correlate of long-term changes of comorbid hypertension: while a history of mild MDD was not associated with changes in CVRFs, moderate MDD was associated with lower blood pressure [systolic: β = - 7.5 (CI - 13.2; - 1.9); diastolic: β = - 4.5 (CI - 7.8; - 1.3)] and a history of bipolar disorder was associated with higher systolic blood pressure at follow-up (β = 14.6; CI 4.9-24.4). Further, severe MDD was weakly associated with a higher BMI at follow-up [β = 1.2 (CI 0.0; 2.4)]. These outcomes were not mediated by use of psychotropic medication and remained statistically significant after adjusting for the use of antihypertensive medication. Since most investigated parameters showed no associations, participants with a lifetime history of MDD in this cohort did not carry a specific risk for a worsening of pre-existing clinically manifest CVRFs. Our findings extend evidence of MDD severity and bipolar disorder as important correlates of long-term changes of arterial hypertension and obesity.

Sections du résumé

BACKGROUND BACKGROUND
Major depressive disorder (MDD) and bipolar disorder are associated with certain cardiovascular risk factors (CVRFs), but it is unclear whether they are associated with unfavourable changes of clinically manifest CVRFs over time.
METHODS METHODS
We used baseline and 12-year follow-up (n = 1887) data from the German Health Interview and Examination Survey 1998. Multivariable linear regression models assessed associations between lifetime CIDI-diagnosed mood disorders at baseline and continuous risk factor-related outcomes (blood pressure, HbA1c, LDL-C, HDL-C, triglycerides, BMI) at follow-up.
RESULTS RESULTS
We did not find consistent deterioration of CVRFs in persons with compared to persons without MDD. Analyses pointed to severity of mood disorder as an important correlate of long-term changes of comorbid hypertension: while a history of mild MDD was not associated with changes in CVRFs, moderate MDD was associated with lower blood pressure [systolic: β = - 7.5 (CI - 13.2; - 1.9); diastolic: β = - 4.5 (CI - 7.8; - 1.3)] and a history of bipolar disorder was associated with higher systolic blood pressure at follow-up (β = 14.6; CI 4.9-24.4). Further, severe MDD was weakly associated with a higher BMI at follow-up [β = 1.2 (CI 0.0; 2.4)]. These outcomes were not mediated by use of psychotropic medication and remained statistically significant after adjusting for the use of antihypertensive medication.
CONCLUSION CONCLUSIONS
Since most investigated parameters showed no associations, participants with a lifetime history of MDD in this cohort did not carry a specific risk for a worsening of pre-existing clinically manifest CVRFs. Our findings extend evidence of MDD severity and bipolar disorder as important correlates of long-term changes of arterial hypertension and obesity.

Identifiants

pubmed: 30014442
doi: 10.1007/s00406-018-0923-1
pii: 10.1007/s00406-018-0923-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

565-576

Subventions

Organisme : Bundesministerium für Gesundheit
ID : Chapter 1501, title 544 01; 1368-1124

Références

Gesundheitswesen. 1998 Dec;60 Suppl 2:S59-68
pubmed: 10063725
Gesundheitswesen. 1999 Dec;61 Spec No:S85-9
pubmed: 10726402
Gesundheitswesen. 1999 Dec;61 Spec No:S90-3
pubmed: 10726403
Psychosom Med. 2000 Mar-Apr;62(2):188-96
pubmed: 10772396
Arch Intern Med. 2000 May 22;160(10):1495-500
pubmed: 10826464
Br J Psychiatry. 2000 May;176:464-7
pubmed: 10912223
Arch Intern Med. 2000 Nov 27;160(21):3278-85
pubmed: 11088090
Arch Gen Psychiatry. 2001 Mar;58(3):221-7
pubmed: 11231827
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Am J Hypertens. 2001 Jul;14(7 Pt 1):660-4
pubmed: 11482304
Arch Gen Psychiatry. 2002 Jan;59(1):77-84
pubmed: 11779286
Am J Prev Med. 2002 Jul;23(1):51-61
pubmed: 12093424
Int J Methods Psychiatr Res. 2002;11(1):1-18
pubmed: 12459800
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Hypertension. 2003 Feb;41(2):207-10
pubmed: 12574083
Psychosom Med. 2003 Mar-Apr;65(2):201-10
pubmed: 12651987
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
Biol Psychiatry. 2003 Aug 1;54(3):200-7
pubmed: 12893096
JAMA. 2003 Oct 22;290(16):2138-48
pubmed: 14570949
Hypertension. 2003 Dec;42(6):1206-52
pubmed: 14656957
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Psychol Med. 2004 May;34(4):597-611
pubmed: 15099415
Bipolar Disord. 2004 Oct;6(5):368-73
pubmed: 15383128
Stat Med. 2005 Oct 15;24(19):2911-35
pubmed: 16152135
J Affect Disord. 2006 Oct;95(1-3):13-7
pubmed: 16777235
Eur Heart J. 2006 Dec;27(23):2763-74
pubmed: 17082208
J Epidemiol Community Health. 2007 Jan;61(1):53-8
pubmed: 17183016
BMJ. 1992 Jan 11;304(6819):75-8
pubmed: 1737142
Psychosom Med. 2007 Apr;69(3):235-41
pubmed: 17420441
BMC Genet. 2007 Sep 10;8:60
pubmed: 17845730
Br J Psychiatry. 2008 Aug;193(2):108-13
pubmed: 18669991
JAMA. 2008 Nov 26;300(20):2379-88
pubmed: 19033588
Psychosom Med. 2009 Apr;71(3):273-9
pubmed: 19196807
Hypertension. 2009 Apr;53(4):631-8
pubmed: 19237679
Psychosom Med. 2009 Jul;71(6):598-606
pubmed: 19561163
Bipolar Disord. 2009 Sep;11(6):657-62
pubmed: 19689508
Diabetes Care. 2010 Jan;33(1):23-8
pubmed: 19837786
Am J Hypertens. 2010 Jan;23(1):62-9
pubmed: 19893498
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
J Psychiatr Res. 2010 Nov;44(15):1010-6
pubmed: 20434171
Lancet. 2010 May 29;375(9729):1875-84
pubmed: 20462635
Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
Hypertension. 2011 Apr;57(4):710-6
pubmed: 21339474
Aust N Z J Psychiatry. 2011 May;45(5):351-69
pubmed: 21500954
Biometrics. 2011 Dec;67(4):1406-13
pubmed: 21627630
Am J Geriatr Psychiatry. 2011 Aug;19(8):721-9
pubmed: 21788922
Diabetes Obes Metab. 2012 Mar;14(3):228-33
pubmed: 21958121
PLoS One. 2012;7(1):e28912
pubmed: 22235252
Lancet. 2012 Aug 11;380(9841):581-90
pubmed: 22607822
J Clin Lipidol. 2012 Jul-Aug;6(4):325-30
pubmed: 22836069
BMC Public Health. 2012 Sep 01;12:730
pubmed: 22938722
Mol Psychiatry. 2013 Jun;18(6):692-9
pubmed: 23089630
Acta Psychiatr Scand. 2013 Oct;128(4):282-93
pubmed: 23216242
Biol Psychiatry. 2013 Mar 1;73(5):406-13
pubmed: 23237315
J Affect Disord. 2013 May;147(1-3):123-7
pubmed: 23246208
Am J Psychiatry. 2013 Mar;170(3):265-74
pubmed: 23361837
PLoS One. 2013;8(1):e55176
pubmed: 23372832
J Clin Endocrinol Metab. 2013 Jun;98(6):2484-93
pubmed: 23553857
Psychiatry Clin Neurosci. 2013 Nov;67(7):532-9
pubmed: 24152284
Psychol Med. 2014 Jul;44(10):2017-28
pubmed: 24262678
Eur J Prev Cardiol. 2014 Mar;21(3):340-6
pubmed: 24491401
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
J Psychosom Res. 2015 Apr;78(4):391-8
pubmed: 25742722
Depress Anxiety. 2015 Oct;32(10):763-73
pubmed: 26114259
Circulation. 2015 Sep 8;132(10):965-86
pubmed: 26260736
Br J Psychiatry. 2016 Jan;208(1):62-8
pubmed: 26294366
Eur J Public Health. 2016 Oct;26(5):867-871
pubmed: 26748100
Psychiatr Prax. 2017 Apr;44(3):148-153
pubmed: 26891102
Mol Psychiatry. 2017 Jul;22(7):1026-1034
pubmed: 27725658
Br J Psychiatry. 2017 Sep;211(3):175-181
pubmed: 28684403
J Psychiatr Res. 1994 Jan-Feb;28(1):57-84
pubmed: 8064641

Auteurs

Sven Speerforck (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany. sven.speerforck@uni-greifswald.de.

F Dodoo-Schittko (F)

Medical Sociology, Institute for Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

S Brandstetter (S)

Medical Sociology, Institute for Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

C Apfelbacher (C)

Medical Sociology, Institute for Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

U Hapke (U)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

F Jacobi (F)

Center of Epidemiology and Longitudinal Studies (CELOS), Technische Universität Dresden, Dresden, Germany.
Psychologische Hochschule Berlin, Berlin, Germany.

H J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

S E Baumeister (SE)

Chair of Epidemiology, Ludwig-Maximilians-Universität München, UNIKA-T, Augsburg, Germany.
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

G Schomerus (G)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH